Proceedings · Session S-390 · filed November 20, 2026

Research Funding & PolicySession paper

Nigeria's industrial pharmacists urge security status for medicine

NAIP chairman Aminu Ezebuilo, newly invested as an academy fellow in Lagos, wants medicine declared a national security matter to cut Nigeria's reliance on drug imports.

By Sophie Lindqvist3 min read524 words

Summary

  • Aminu Ezebuilo, NAIP national chairman, called for medicine to be declared a matter of national security.
  • He spoke after receiving the FNAPharm fellowship at the Nigeria Academy of Pharmacy's 2026 investiture in Lagos.
  • The investiture theme was 'Pharmacy for National Health Security'.
  • WHO Nigeria head Pavel Ursu delivered the keynote address.
Declare medicine matter of national security, industrial pharmacists’ chief tasks FG
FigureDeclare medicine matter of national security, industrial pharmacists’ chief tasks FG — HeungSoon / pixabay

Nigeria's government should declare medicine a matter of national security, Aminu Ezebuilo, national chairman of the Association of Industrial Pharmacists of Nigeria (NAIP), said in an interview with CEOAFRICA, arguing the step is the fastest route to reducing the country's dependence on imported medicines.

Ezebuilo made the call shortly after receiving the Fellowship of the Nigeria Academy of Pharmacy (FNAPharm) at the academy's 2026 investiture of new fellows, held at the Old Great Hall, College of Medicine, University of Lagos, Idi-Araba. The ceremony ran under the theme "Pharmacy for National Health Security: Advancing Innovation, Medicine Sovereignty and Sustainable Healthcare."

What would the designation change?

According to Ezebuilo, declaring medicine a matter of national security would signal the Federal Government's commitment to protecting the healthcare system and to creating an enabling environment in which local pharmaceutical manufacturers can thrive. He framed the designation not as symbolism but as a precondition for policy action.

He said Nigeria must prioritise the development of its local pharmaceutical manufacturing industry through three instruments: deliberate government policies, strategic investments and sustainable support mechanisms. Without institutional, financial and policy backing, he argued, local manufacturers cannot compete effectively or expand production capacity.

Why does import dependence matter?

Ezebuilo positioned indigenous drug production as fundamental to three outcomes: reducing dependence on imported medicines, safeguarding the pharmaceutical supply chain and ensuring uninterrupted access to essential medicines for Nigerians. His statement tracks with the country's exposure to supply-chain disruptions and other external pressures, a vulnerability the sector has been trying to reduce.

His assessment is blunt on sequencing. Nigeria's ambition to achieve medicine sovereignty, he said, will remain difficult to realise as long as the necessary support structures for local manufacturers are missing. The call therefore functions as a portfolio-level argument: treat pharmaceutical production capacity as strategic infrastructure rather than a commercial sector left to market forces.

What did the fellowship recognise?

The Nigeria Academy of Pharmacy awarded Ezebuilo the fellowship in recognition of his professional excellence, leadership contributions and commitment to advancing the pharmacy profession. He described the honour as both a recognition and a call to greater responsibility, and thanked the academy's leadership — particularly its president and chairman of the governing council, Lere Baale — for considering him worthy.

"The reward for hard work is more work," Ezebuilo said, reaffirming his commitment to professional excellence, purposeful leadership and sustained contributions to industrial pharmacy and the broader healthcare sector.

Who else spoke?

Pavel Ursu, the World Health Organisation's representative and head of mission in Nigeria, delivered the keynote address. He highlighted pharmacy's role in strengthening national health security, promoting innovation, advancing medicine sovereignty and ensuring sustainable access to safe and quality medicines — placing the WHO's country office behind the same agenda NAIP is pushing.

The convergence matters for R&D and manufacturing managers watching the Nigerian market: a professional association, a national academy and the WHO country mission are now aligned on medicine sovereignty as a policy frame. Whether the Federal Government converts that alignment into the funding, policy and institutional support Ezebuilo demands will determine if local production capacity actually scales.

via businessday.ng (Source)

Filed under

  • pharmaceutical-manufacturing
  • medicine-sovereignty
  • national-health-security
  • import-dependence
  • supply-chain-resilience
Share this article:

More from Sophie Lindqvist

Sophie Lindqvist

Show full bio

Correspondent covering money, funding and market shifts around research and development at Hypothesis Wire.

246 articles

References

  1. Nigeria grants N24bn pharma tax waivers for 2025–2026
  2. Nigeria demands equity and technology transfer in pandemic preparedness
  3. 2026 Access to Medicine Index: Africa's Three Biggest Markets Left Off Access Plans
  4. Tinubu commits N18bn to Nigerian health university, backs research funding
  5. Ghana Targets First Locally Made Vaccine by Q1 2027

« Previous articleNext article »